Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model.
暂无分享,去创建一个
B. Roques | R. Maldonado | J. Micó | C. Smadja | J. Gibert-Rahola | P. Tejedor-Real | J. Gilbert-Rahola | Bernard P. Roques | P. Tejedor‐Real | Claire Smadja | Rafael Maldonado
[1] P. Coric,et al. CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins , 1997, Psychopharmacology.
[2] Brigitte L. Kieffer,et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.
[3] H. Steiner,et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.
[4] B. Roques,et al. The Dual Peptidase Inhibitor RB101 Induces a Long‐Lasting Increase in the Extracellular Level of Met‐Enkephalin‐Like Material in the Nucleus Accumbens of Freely Moving Rats , 1996, Journal of neurochemistry.
[5] B. Roques,et al. Implication of endogenous opioid system in the learned helplessness model of depression , 1995, Pharmacology Biochemistry and Behavior.
[6] S. Lukas,et al. Buprenorphine treatment of refractory depression. , 1995, Journal of clinical psychopharmacology.
[7] R. Maldonado,et al. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[8] B. Roques,et al. Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat , 1993, Biological Psychiatry.
[9] M. Fournié-Zaluski,et al. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice. , 1993, European journal of pharmacology.
[10] M. Fournié-Zaluski,et al. Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101. , 1992, European journal of pharmacology.
[11] J. Gillin,et al. Association of beta-endorphin with specific clinical symptoms of depression. , 1992, The American journal of psychiatry.
[12] F Noble,et al. "Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes. , 1992, Journal of medicinal chemistry.
[13] M. Fournié-Zaluski,et al. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation. , 1992, European journal of pharmacology.
[14] S. Turcaud,et al. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding , 1992, Brain Research.
[15] J. Slangen,et al. Animal Models in Psychopharmacology , 1991, APS: Advances in Pharmacological Sciences.
[16] G. Di Chiara,et al. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[17] B. Roques,et al. Improved quantitative radioautography of rat brain δ-opioid binding sites using [3H]DSTBULET, a new highly potent and selective linear enkephalin analogue , 1990, Neurochemistry International.
[18] B. Roques,et al. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of δ-opioid receptors , 1990, Peptides.
[19] I. Kitchen,et al. Antagonism of swim‐stress‐induced antinociception by the δ‐opioid receptor antagonist naltrindole in adult and young rats , 1990, British journal of pharmacology.
[20] J. Féger,et al. Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats , 1990, Neuropharmacology.
[21] J. Fuentes,et al. Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. , 1989, European journal of pharmacology.
[22] M. E. Lewis,et al. Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.
[23] B. Roques,et al. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors. , 1988, Journal of medicinal chemistry.
[24] S. Daenen,et al. CURE OF PSEUDOMONAS AERUGINOSA INFECTION IN NEUTROPENIC PATIENTS BY CONTINUOUS INFUSION OF CEFTAZIDIME , 1988, The Lancet.
[25] B. Roques,et al. [3H][D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6(O-tert-butyl). Two new enkephalin analogs with both a good selectivity and a high affinity toward delta-opioid binding sites. , 1988, The Journal of biological chemistry.
[26] N. Nair,et al. The effect of electroconvulsive therapy on endorphins in depression , 1988, Biological Psychiatry.
[27] P. Soubrié,et al. Reversal of helpless behavior in rats by putative 5-HT1A agonists , 1988, Biological Psychiatry.
[28] P. Portoghese,et al. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist , 1988 .
[29] E. Hamel,et al. Neutral endopeptidase-24.11, μ and δ opioid receptors after selective brain lesions: an autoradiographic study , 1987, Brain Research.
[30] T. Shippenberg,et al. Motivational properties of opioids: evidence that an activation of σ-receptors mediates reinforcement processes , 1987, Brain Research.
[31] M. Hamon,et al. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline , 1987, Neuropharmacology.
[32] J. Glowinski,et al. Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. , 1986, European journal of pharmacology.
[33] K. Isenberg,et al. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. , 1984, European journal of pharmacology.
[34] P. Kalivas,et al. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. , 1983, The Journal of pharmacology and experimental therapeutics.
[35] M. Zimmermann,et al. Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.
[36] J. Rossier,et al. β‐ENDORPHIN IMMUNOREACTIVITY IN THE PLASMA OF PSYCHIATRIC PATIENTS RECEIVING ELECTROCONVULSIVE TREATMENT * , 1982, Annals of the New York Academy of Sciences.
[37] S. Maier,et al. The nature of the activity deficit produced by inescapable shock , 1982 .
[38] F. Petty,et al. Specificity of the learned helplessness model of depression , 1982, Pharmacology Biochemistry and Behavior.
[39] J. Weiss,et al. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain , 1981, Brain Research Reviews.
[40] Douglas L. Jones,et al. From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.
[41] W. Bunney,et al. PLASMA OPIOID ACTIVITY IN MANIC-DEPRESSIVE ILLNESS , 1980, The Lancet.
[42] A. Biegon,et al. Interaction of tricyclic antidepressants with opiate receptors. , 1980, Biochemical pharmacology.
[43] J. Holaday,et al. The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate , 1979, Brain Research.
[44] M. Fischler,et al. beta-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders. , 1979, Pharmakopsychiatrie, Neuro-Psychopharmakologie.
[45] A. Lajtha,et al. Beta-endorphine-induced changes in schizophrenic and depressed patients N.S. Kline, C.H. Li, H.E. Lehmann, A. Lajtha, E. Laski and T. Cooper, Arch. gen. Psychiat., 34 (1977) 1111–1113 , 1979, PAIN.
[46] A. Lajtha,et al. β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients , 1977 .
[47] M. Seligman,et al. Learned helplessness: Theory and evidence. , 1976 .
[48] S. Maier,et al. Influence of control of shock on subsequent shock-elicited aggression. , 1972, Journal of comparative and physiological psychology.
[49] D. Naber. Opioids in the Etiology and Treatment of Psychiatric Disorders , 1993 .
[50] J. Micó,et al. Relationship Between Emotivity Level and Susceptibility to the Learned Helplessness Model of Depression in the Rat , 1991 .
[51] P. Willner. Animal models of depression: an overview. , 1990, Pharmacology & therapeutics.
[52] T. Kameyama,et al. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). , 1988, The Journal of pharmacology and experimental therapeutics.
[53] S. Maier,et al. Learned helplessness, inactivity, and associative deficits: effects of inescapable shock on response choice escape learning. , 1980, Journal of experimental psychology. Animal behavior processes.